Saad Kareem 4
4 · GeneDx Holdings Corp. · Filed Mar 12, 2024
Insider Transaction Report
Form 4
Saad Kareem
Chief Business Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-03-09+2,841→ 27,308 total - Exercise/Conversion
Restricted Stock Unit
2024-03-09−2,841→ 31,249 total→ Class A Common Stock (2,841 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.